Press Releases
Quanticate partners with Cancer Research UK to launch DETERMINE Study
Quanticate, a global data-focused clinical research organisation (CRO), has partnered with leading cancer research organisation, Cancer Research UK, to launch the DETERMINE study which will test a range of therapies specifically targeting key genetic changes in cancer cells.
The first...
Press Releases
Monon Bioventures receives nearly $400,000 to develop Purdue-discovered glioblastoma treatment
Monon Bioventures LLC has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR, grant from the National Cancer Institute to demonstrate the feasibility of manufacturing a glioblastoma therapeutic created at the Purdue University College of Pharmacy.
“Glioblastoma is one...
Press Releases
Debut Event Showcases Newest Trends in Drug Manufacturing and Delivery
Connect in Pharma — the new annual event from Easyfairs — had its debut launch on 14 & 15 September in Geneva. Key players from companies in the pharmaceutical industry, including Bayer, Merck, Pfizer, Roche, Johnson & Johnson and...
Press Releases
Abzena strengthens R&D capabilities to support rapid antibody discovery
Abzena, a leading CDMO providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has announced a significant upgrade to its research and development capabilities in Cambridge. This includes an investment in B cell discovery technologies...
Press Releases
Bora Pharmaceuticals partners with TaiRx, Inc. to manufacture breakthrough anticancer drug
Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals has partnered with TaiRx, Inc., a premier Taiwan new drug development company, to manufacture a novel anticancer drug, CVM-1118.
CVM-1118 is a new small molecule chemical entity being developed by...
Press Releases
Peli BioThermal Opens New Service Center In Japan
Peli BioThermal, the life science industry’s partner from discovery to distribution, announces the opening of its new service center in Japan. The new facility, which is the latest location to be added to the company’s growing network in Asia,...
Press Releases
MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea
MedPharm, a global provider of contract topical and transdermal formulation development and manufacturing services, is pleased to announce that it will support Swiss Biotech company, Mosanna Therapeutics, in the development of a nasal spray (MOS-118) aimed at treating Metabolic...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















